SB 206 amends Oklahoma law to classify emergency medical services (EMS) provided by public entities - such as municipal, county, or district ambulance services - as "essential services" **solely for eligibility for federal funding**. This change directly affects public EMS providers seeking federal grants, ensuring they meet the federal definition of "essential services" under current funding criteria. The bill does not alter EMS operations or create new requirements but adjusts the legal classification to align with federal funding rules. It was introduced as an emergency measure to take immediate effect upon approval.
This bill approves specific permanent rules proposed by the Oklahoma Medical Marijuana Authority, which will govern how medical marijuana is regulated in the state. By signing off on these rules, the legislature allows the authority to enforce new guidelines for medical marijuana programs. The resolution also instructs the Secretary of State to send copies of the approved rules to the Governor and the editor of The Oklahoma Register.
HB 4423 requires the Oklahoma Health Care Authority to verify the immigration status of all Medicaid applicants using the federal SAVE system (or its successor) before approving benefits. It specifically mandates that the Authority notify U.S. Immigration and Customs Enforcement (ICE) if an applicant's status cannot be verified as lawful. This applies to all applicants, including adults applying for child-only Medicaid benefits on behalf of a child. The bill takes effect October 1, 2026, and does not change Medicaid eligibility criteria but adds a verification step for immigration status.
SB 740 amends Oklahoma's mental health definitions to modernize terminology and clarify eligibility for care. It replaces outdated terms like "insane" and "mental disease" with "mental illness" throughout the law and defines key terms such as "person requiring treatment" (based on specific risk criteria like immediate harm to self/others) and "licensed mental health professional" (including psychiatrists, psychologists, and counselors). The bill directly affects mental health facilities, providers, and individuals receiving care by standardizing how these terms are used in legal documents, admission processes, and treatment decisions. It does not create new services or funding but ensures consistent application of existing mental health laws.
SB 1794 requires Oklahoma's Department of Mental Health to create a real-time statewide registry tracking mental health facility availability, directly affecting hospitals and clinics that serve patients. The registry will display current capacity, populations served, diagnostic details (without patient identifiers), admission criteria, and emergency placement contacts to improve urgent care access. Facilities must electronically update their capacity hourly (or per department rules for low-volume settings) and comply with privacy laws like HIPAA. The bill takes effect November 1, 2026, aiming to streamline emergency placements without sharing identifiable patient data.
SB 1553 amends Oklahoma's Medicaid appeal process to ensure appeals for denied claims are reviewed by qualified mental health professionals. It requires reviewers (like psychologists) to hold valid licenses, have relevant clinical experience, and avoid conflicts of interest, while banning automated review systems. The bill also establishes that if an appeal successfully reverses a denied claim, the psychologist or mental health provider can recover costs for time spent on the appeal. This directly affects Medicaid members, providers, and mental health professionals handling appeals.
HB 3265 amends Oklahoma's police pension law to clarify disability benefit eligibility for law enforcement officers. It specifically expands the definition of "mental health specialist" to include licensed psychologists for disability certification (Section G). The bill establishes a clear benefit scale based on disability percentage (e.g., 50-74% impairment equals 75% of accrued retirement benefit) and presumes line-of-duty disability for officers exposed to hazardous substances like chemicals or blood-borne pathogens, unless proven otherwise (Section I). These changes directly affect Oklahoma police officers seeking disability benefits through the Oklahoma Police Pension and Retirement System.
HB 3644 (the Blake Burgess Act) requires hospitals with emergency departments and ambulatory surgical centers to implement standardized VTE (venous thromboembolism, or blood clot in veins) risk assessments for patients using nationally recognized tools and provide annual training to non-physician clinical staff. It mandates a statewide VTE registry managed by a private, nonprofit entity meeting specific criteria, which hospitals must report to starting July 2027 with data including patient age, zip code, sex, diagnosis details, and treatment. The registry collects information to improve VTE care quality, monitor outcomes, and inform state health reports, with hospitals required to submit data on VTE incidence, patient demographics, and treatment. The law directly affects hospitals, ambulatory surgical centers, and their clinical staff through new screening, training, and reporting obligations.
HB 3834, the "Oklahoma Breakthrough Therapy Act," establishes a framework for ibogaine clinical trials in Oklahoma. It requires drug developers to match state funding for trials, provide detailed plans for FDA approval and post-approval patient access (including priority for state residents and low-income care), and share intellectual property proceeds with the state. These proceeds fund an "Ibogaine Intellectual Property Account" managed by the State Treasurer, which must be spent on programs for at-risk populations with conditions treatable by ibogaine (like opioid use disorder). The bill also protects Oklahoma-licensed medical professionals from adverse licensing actions for recommending ibogaine therapy.
HB 3767 adds specific synthetic drugs and substances to Oklahoma's Schedule I and IV of controlled dangerous substances under state law. It directly affects anyone possessing, distributing, or using the newly listed compounds, including various fentanyl analogs (like para-fluorofentanyl), synthetic hallucinogens (like psilocybin and salvia), and other novel psychoactive substances. The bill amends Oklahoma's Controlled Dangerous Substances Act by expanding the official lists in Schedule I (substances with no medical use and high abuse potential) and Schedule IV (substances with accepted medical use but potential for abuse). This creates new legal prohibitions for these substances without requiring additional medical or legal exceptions.
